These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38629365)

  • 61. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.
    Peng X; Yu M; Chen J
    J Int Med Res; 2020 Sep; 48(9):300060520950912. PubMed ID: 32878513
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
    Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
    World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway.
    Zhu L; Dai L; Yang N; Liu M; Ma S; Li C; Shen J; Lin T; Wang D; Pan W; Li X
    Cell Biochem Funct; 2020 Jul; 38(5):621-629. PubMed ID: 32153043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance.
    Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
    Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
    J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
    Yang X; Zhang Q; Yang X; Zhao M; Yang T; Yao A; Tian X
    Biochem Biophys Res Commun; 2019 Apr; 511(4):719-724. PubMed ID: 30827507
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis.
    Wu Y; Gu W; Han X; Jin Z
    J Cell Mol Med; 2021 Sep; 25(17):8229-8243. PubMed ID: 34288373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition.
    Jiao Z; Huang L; Sun J; Xie J; Wang T; Yin X; Zhang H; Chen J
    Histochem Cell Biol; 2020 Aug; 154(2):215-230. PubMed ID: 32382787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
    Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overexpression of SMYD3 in Ovarian Cancer is Associated with Ovarian Cancer Proliferation and Apoptosis via Methylating H3K4 and H4K20.
    Jiang Y; Lyu T; Che X; Jia N; Li Q; Feng W
    J Cancer; 2019; 10(17):4072-4084. PubMed ID: 31417652
    [No Abstract]   [Full Text] [Related]  

  • 72. The pleiotropic mouse phenotype extra-toes spotting is caused by translation initiation factor Eif3c mutations and is associated with disrupted sonic hedgehog signaling.
    Gildea DE; Luetkemeier ES; Bao X; Loftus SK; Mackem S; Yang Y; Pavan WJ; Biesecker LG
    FASEB J; 2011 May; 25(5):1596-605. PubMed ID: 21292980
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ECSIT inhibits cell death to increase tumor progression and metastasis via p53 in human breast cancer.
    Hu Y; Liu W; Zhang X; Liu D
    Transl Cancer Res; 2022 Apr; 11(4):699-709. PubMed ID: 35571656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting EIF3C to suppress the development and progression of nasopharyngeal carcinoma.
    Zhao Q; Luo X; Li H; Bai Y; Chen Q; Yang M; Pei B; Xu C; Han S
    Front Bioeng Biotechnol; 2022; 10():994628. PubMed ID: 36147539
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
    Zhu H; Diao S; Lim V; Hu L; Hu J
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
    [TBL] [Abstract][Full Text] [Related]  

  • 78. UBP43 promotes epithelial ovarian carcinogenesis via activation of β-catenin signaling pathway.
    Xie H; Chen J; Ma C; Zhao J; Cui M
    Cell Biol Int; 2023 Aug; 47(8):1427-1440. PubMed ID: 37186433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathway.
    Chang X; Tamauchi S; Yoshida K; Yoshihara M; Yokoi A; Shimizu Y; Ikeda Y; Yoshikawa N; Kiyono T; Yamamoto Y; Kajiyama H
    Gynecol Oncol; 2023 Jun; 173():31-40. PubMed ID: 37075494
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Upregulation of
    Wu L; Ling ZH; Wang H; Wang XY; Gui J
    Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.